Drug Week

Health Information - No more medical roulette: Publisher says internet will change in 2003

Hepatitis B Immune Globulin Therapy - Liver transplant indication BLA submitted for Nabi-HB Intravenous

Hepatitis C Therapy - Civacir receives orphan drug designation

Hormone Therapy - Hormone therapy technology licensed From Wake Forest

Hypertension - Forest updates status of lercanidipine regulatory submission

Immunosuppression - Butyrate has multiple effects on human monocyte-derived DCs, macrophages

Infectious Disease Therapy - Azithromycin effective against Shiga toxin-producing E. coli

Infectious Disease Therapy - Yeast adhesin analogs can prevent intestinal C. albicans infection

Lymphocytic Leukemia - Phase II study data reported on rituximab + fludarabine immunotherapy

Macular Edema - Enrollment complete for in phase II trial for PME treatment

Malaria - New drug shows early promise

Medication Errors - Baxter launches enhanced bar coding and information system technology

Metastatic Breast Cancer - Enrollment for pivotal phase III trial of ABI-007 completed

Migraine - Clinical data: Zomig-ZMT delivers early and sustained headache response

Multiple Myeloma - Novel drug continues to show promise in early study

Multiple Sclerosis - Betaferon now available at room temperature in the E.U.

Multiple Sclerosis - MS patients on Rebif more likely to remain relapse free

Non-Hodgkin Lymphoma - Positive pivotal phase II/III clinical trial results achieved for Onco TCS

Non-Small Cell Lung Cancer - FDA approves Taxotere for first-line treatment of patients

Nosocomial Infections - Increasing antibiotic resistance a major hospital crisis

Ophthalmology - Bucillamine suppresses choroidal neovascularization in rat model

Organ Transplant Rejection - HuMax-TAC program announced

Osteoarthritis - Pennsaid wins approvable letter from Health Canada

Pain Medicine - Company announces SGX 355, drug development candidate for neuropathic pain

Pain Medicine - U.S. Patent issued on Contulakin-G to treat pain; CGX-1160 safety trial over

Percutaneous Coronary Intervention - Long-term treatment with clopidogrel and aspirin significantly cuts risk

Pharmacodynamics - Antiangiogenic agent, Neovastat, induces endothelial cell apoptosis

Pharmacokinetics - Diacetylmorphine degradation in cell culture studied

Postoperative Ileus - Enrollment complete for phase III POI study for alvimopan

Product Rights Acquisition - Barr to acquire currently marketed products, including Ziac

Psoriatic Arthritis - Infliximab is effective, safe in clinical trial

Regulatory Issues - FDA's new head pledges more action against misleading ads

Schering-Plough Corp. - Peg-Intron and Rebetol pass 150,000-patients-treated mark in U.S.

Sleep Apnea - Approval granted to expand marketing of Provigil in the United Kingdom

Stem Cell Transplantation - Granulocyte colony-stimulating factor can hasten pediatric recovery

Therapeutic Programs - Cancer/immunotherapy company updates progress in commercial strategies

Trends - More consumers are asking their doctors for drug samples by name